Literature DB >> 8499479

The effect of sequence variations and structure on the cytolytic activity of melittin peptides.

J A Werkmeister1, A Kirkpatrick, J A McKenzie, D E Rivett.   

Abstract

The importance of various amino acid residues in melittin for cytolytic function against mammalian cells was assessed by use of a monoclonal antibody to the C-terminal region, synthesis of peptide analogues and chemical modification of specific residues. A monoclonal anti-melittin antibody directed to the basic C-terminal region inhibited cytolytic activity. Consistent with this, deletion of one of the two Lys Arg sequences at the C terminal end of the peptide reduced cytolysis 8-fold, although significant activity was still present. A similar reduction in activity was also found with a synthetic analogue which had the reverse sequence to melittin. In contrast, when the last 6 residues of the C-terminal region were transferred to the N-terminus, a peptide with markedly reduced activity was obtained. Chemical modification of lysine and arginine residues of melittin indicated that lysine was only minimally important for functional activity compared with arginine which was essential. In particular, our results demonstrate that substitution of serine for lysine 7 has no significant effect on the activity of the peptide and suggest that this residue is important only in maintaining the amphipathic helix of the peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499479     DOI: 10.1016/0304-4165(93)90077-l

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.

Authors:  Hua Pan; Jacob W Myerson; Olena Ivashyna; Neelesh R Soman; Jon N Marsh; Joshua L Hood; Gregory M Lanza; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2010-03-24       Impact factor: 5.191

2.  A molecular dynamics study of the bee venom melittin in aqueous solution, in methanol, and inserted in a phospholipid bilayer.

Authors:  Alice Glättli; Indira Chandrasekhar; Wilfred F van Gunsteren
Journal:  Eur Biophys J       Date:  2005-12-02       Impact factor: 1.733

3.  Peptide inhibitors of melittin action.

Authors:  D Hewish; J Werkmeister; A Kirkpatrick; C Curtain; G Pantela; D E Rivett
Journal:  J Protein Chem       Date:  1996-05

4.  Online monitoring of metabolism and morphology of peptide-treated neuroblastoma cancer cells and keratinocytes.

Authors:  Sabine Drechsler; Jörg Andrä
Journal:  J Bioenerg Biomembr       Date:  2011-06-04       Impact factor: 2.945

5.  Effects of Peptide Charge, Orientation, and Concentration on Melittin Transmembrane Pores.

Authors:  Almudena Pino-Angeles; Themis Lazaridis
Journal:  Biophys J       Date:  2018-06-19       Impact factor: 4.033

6.  Postformulation peptide drug loading of nanostructures.

Authors:  Hua Pan; Jon N Marsh; Eric T Christenson; Neelesh R Soman; Olena Ivashyna; Gregory M Lanza; Paul H Schlesinger; Samuel A Wickline
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

7.  Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.

Authors:  Jörg Andrä; Torsten Goldmann; Christoph M Ernst; Andreas Peschel; Thomas Gutsmann
Journal:  J Biol Chem       Date:  2011-04-07       Impact factor: 5.157

8.  Dimerization of truncated melittin analogues results in cytolytic peptides.

Authors:  D E Rivett; A Kirkpatrick; D R Hewish; W Reilly; J A Werkmeister
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

9.  Molecular dynamics simulation of melittin in a dimyristoylphosphatidylcholine bilayer membrane.

Authors:  S Bernèche; M Nina; B Roux
Journal:  Biophys J       Date:  1998-10       Impact factor: 4.033

10.  Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus.

Authors:  Ludovico Migliolo; Osmar N Silva; Paula A Silva; Maysa P Costa; Carolina R Costa; Diego O Nolasco; João A R G Barbosa; Maria R R Silva; Marcelo P Bemquerer; Lidia M P Lima; Maria T V Romanos; Sonia M Freitas; Beatriz S Magalhães; Octavio L Franco
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.